Astera Labs, Inc. (ALAB)

From the record

Astera Labs, Inc.'s filings since 2018 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Astera Labs, Inc.'s 4 filed years say what it did: revenue went from $80 million in fiscal 2022 to $853 million in fiscal 2025, up 120.1% a year; it rose in 3 of 3 years; it never fell from a peak; net income was positive in 1 of 4 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Astera Labs, Inc.'s diluted share count grew about 73.8% a year, and dividends and buybacks returned about 0% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 507 sales (362 under scheduled 10b5-1 plans) and 0 purchases of their own stock on the open market in the year to 2026-11-09 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Astera Labs, Inc. earned about 16 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 42 cents per dollar of everything the company owns. Leverage: it owed about 11 cents per dollar of assets, and net share issuance: its share count grew 36.8% over the year (the filed statements).

From the record

Astera Labs, Inc.'s standing among 97 graded names in its industry family: revenue of $853 million in fiscal 2025 ranks in the top 45% by size; a net margin of 25.7% ranks in the top 14%; revenue growth of 120.1% a year over the last 3 filed years ranks in the top 7% (its annual reports).

From the record

Astera Labs, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $168 million against no long-term debt tagged leaves 10.9% of its assets as net cash, top 50% of its family; cash from operations less capital spending is 33.1% of revenue (top 7%); a gross margin of 75.7% (top 6%); research spending of 35.7% of revenue (top 26%) (its annual report).

From the record

Astera Labs, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 120.1% a year over the last three filed years against 120.1% over all 4, speeding up (top 28% of its family); the newest year grew 115.2% (top 7%); research spending grew 60.3% a year (top 3%); capital spending grew 113.2% a year (top 6%) (its annual reports). Astera Labs, Inc. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

From the record

Astera Labs, Inc.'s newest year against its own record: revenue of $853 million in fiscal 2025 came in 3.4% below the $882 million its prior three years' pace pointed to (bottom 18% of its family); net income of $219 million against a prior three-year average of $56 million (top 7%); a net margin of 25.7% against -38.9% before (top 9%) (its annual reports).